CIK 0001833769 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Hyperfine, Inc.
Sign in to watch- Ticker
- HYPR
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 866-796-6767
- Business address
- 351 NEW WHITFIELD STREET, GUILFORD, CT, 06437
- Former names
- HealthCor Catalio Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,545
- in 2 filings
Net −$12,545. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 18 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-24 | TEISSEYRE THOMAS Chief Operating Officer | Sale | −7,345 | $0.85 | $6K | 671,256 |
| 2026-08-24 | HALE BRETT CFO and CAO | Sale | −7,345 | $0.85 | $6K | 592,420 |
| 2026-06-03 | Wolterman Dan Director | Grant or award · Stock Options (right to buy) | +52,600 | 52,600 | ||
| 2026-05-26 | HALE BRETT CFO and CAO | Sale | −6,047 | $1.65 | $10K | 599,765 |
| 2026-05-26 | TEISSEYRE THOMAS Chief Operating Officer | Sale | −6,047 | $1.65 | $10K | 678,601 |
| 2026-05-22 | Fattori Ruth A Director | Grant or award · Stock Options (right to buy) | +157,700 | 157,700 | ||
| 2026-05-22 | Wolterman Dan Director | Grant or award · Stock Options (right to buy) | +157,700 | 157,700 | ||
| 2026-05-22 | Dahldorf John T Director | Grant or award · Stock Options (right to buy) | +157,700 | 157,700 | ||
| 2026-05-22 | ROTHBERG JONATHAN M Director | Grant or award · Stock Options (right to buy) | +157,700 | 157,700 | ||
| 2026-03-31 | HALE BRETT CFO and CAO | Grant or award | +330,000 | 605,812 | ||
| 2026-03-31 | TEISSEYRE THOMAS Chief Operating Officer | Grant or award | +330,000 | 684,648 | ||
| 2026-03-31 | Sainz Maria President and CEO | Grant or award | +750,000 | 789,586 | ||
| 2026-03-23 | TEISSEYRE THOMAS Chief Operating Officer | Sale | −24,188 | $1.21 | $29K | 354,648 |
| 2026-03-23 | HALE BRETT CFO and CAO | Sale | −24,188 | $1.21 | $29K | 275,812 |
| 2026-02-13 | TEISSEYRE THOMAS Chief Operating Officer | Sale | −821 | $1.11 | $913 | 378,836 |
| 2025-11-19 | TEISSEYRE THOMAS Chief Operating Officer | Sale | −1,405 | $1.08 | $2K | 379,657 |
| 2025-08-18 | TEISSEYRE THOMAS Chief Operating Officer | Sale | −1,151 | $1.33 | $2K | 381,062 |
| 2025-06-05 | Wolterman Dan Director | Grant or award · Stock Options (right to buy) | +81,817 | 81,817 | ||
| 2025-05-20 | Fattori Ruth A Director | Grant or award · Stock Options (right to buy) | +79,200 | 79,200 | ||
| 2025-05-20 | Wolterman Dan Director | Grant or award · Stock Options (right to buy) | +79,200 | 79,200 |
Page 1 of 8 · 149 trades